- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06626217
Comparison of Perfusion Index Monitoring Using a Smartwatch and a Pulse Oximeter (PIWATCH)
October 1, 2024 updated by: Czech Technical University in Prague
The aim of the study is to experimentally compare measured perfusion index values between smartwatch and a medical grade pulse oximeter in healthy subjects at rest and with and without motion artifacts and during exercise.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Perfusion index (PI) is one of the many vital signs monitored to assess the clinical status of a patient.
PI is determined from the pulsatile part of the plethysmographic curve, with typical values measured on the fingers ranging from 0.02% to 20%.
Although PI is a relatively newly measured parameter, it has already found application in many areas of clinical medicine.
For example, continuous measurement of the perfusion index has been used to monitor changes in finger blood flow after finger replantation (surgical reattachment of the finger to the patient's body).
As the ability to monitor the perfusion index begins to become part of the monitored parameters of smartwatches, this new feature could be used in situations where the use of finger sensors is not appropriate.
However, no comparison of perfusion index measurements between smartwatch and pulse oximeter has been made to date.
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Simon Walzel, MEng.
- Phone Number: 420724836120
- Email: walzesim@fbmi.cvut.cz
Study Contact Backup
- Name: Karel Roubik, Prof.
- Email: roubik@fbmi.cvut.cz
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Healthy Adult Volunteer
Exclusion Criteria:
- Post-traumatic upper limb conditions affecting finger or arm perfusion
- Injuries or diseases of the skin of the fingers and arm
- Any acute phase of any disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Comparison of perfusion index monitoring using a smartwatch and a pulse oximeter
Placing the finger pulse oximeter sensor on the left middle finger and placing the Massimo Watch W1 on the volunteer's left wrist (2 cm from the processus styloideus).
Four interventions subsequently follow (Resting condition, Movement artifacts and Circulation constriction, Physical Exercise).
|
The volunteers hand is at rest and Perfusion index readings are taken for six minutes from pulse oximeter and smartwatch
The volunteer periodically spreads his/her fingers and clenches them into a fist, and Perfusion index readings are taken for six minutes from pulse oximeter and smartwatch.
The volunteers arm is constricted using a cuff to measure non-invasive blood pressure.
The perfusion index value is monitored during the time of cuff pressure and cuff release.
The measurement is followed by a 4-minute pause to allow the vascular supply to stabilize.
The measurement is repeated three times.
The volunteer is seated on the exercise bike, rests his forearms on the handlebars and is instructed not to move his arms.
The volunteer's heart rate is controlled to increase to 120 beats per minute.
For five minutes, the perfusion index is recorded from a pulse oximeter and smartwatch.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of measured perfusion index values between pulse oximeter and smartwatch during different interventions.
Time Frame: 1 hour
|
The comparison of measured perfusion index values between pulse oximeter and smartwatch during different interventions (Resting conditions, Movement artifacts, Circulation costriction and Physical exercise) will be analyzed.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Karel Roubik, Czech Technical University, Fac. of Biomedical Engineering
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
October 8, 2024
Primary Completion (Estimated)
April 30, 2025
Study Completion (Estimated)
August 30, 2025
Study Registration Dates
First Submitted
October 1, 2024
First Submitted That Met QC Criteria
October 1, 2024
First Posted (Actual)
October 3, 2024
Study Record Updates
Last Update Posted (Actual)
October 3, 2024
Last Update Submitted That Met QC Criteria
October 1, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- NVT_02_2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The measured data will be shared publicly in the data repository on web page: https://ventilation.fbmi.cvut.cz/data/
IPD Sharing Time Frame
Unlimited from the time of processing complete measured data
IPD Sharing Access Criteria
Publicly available to everyone
IPD Sharing Supporting Information Type
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.